Online citations, reference lists, and bibliographies.
← Back to Search

Vault Particles: A New Generation Of Delivery Nanodevices.

A. Casañas, P. Guerra, I. Fita, N. Verdaguer
Published 2012 · Computer Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Vault particles possess many attributes that can be exploited in nanobiotechnology, particularly in the creation of drug delivery nanodevices. These include self-assembly, 100 nm size range, a dynamic structure that may be controlled for manipulation of drug release kinetics and natural presence in humans ensuring biocompatibility. The flexibility and the adaptability of this system have been greatly enhanced by the emerging atomic-level information and improved comprehension of vault structure and dynamics. It seems likely that this information will allow their specific tailoring to the individual requirements of each drug and target tissue. These properties provide vaults with an enormous potential as a versatile delivery platform.
This paper references
10.1021/nn8008504
Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer.
Cheng-Yu Lai (2009)
10.1038/nrd1960
Artificial viruses: a nanotechnological approach to gene delivery
Enrico Mastrobattista (2006)
10.1371/journal.pone.0005409
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
C. Champion (2009)
10.1074/JBC.M313955200
The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling*
S. Kolli (2004)
10.1021/BI026747E
Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes?
K. Suprenant (2002)
10.1021/nn900555d
Utilization of a protein "shuttle" to load vault nanocapsules with gold probes and proteins.
Lisa E Goldsmith (2009)
10.1083/JCB.146.5.917
The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase
V. Kickhoefer (1999)
10.1074/jbc.274.46.32712
Vaults and Telomerase Share a Common Subunit, TEP1*
V. Kickhoefer (1999)
10.1038/nm0695-578
The drug resistance-related protein LRP is the human major vault protein
G. Scheffer (1995)
10.1021/nl080536z
Reversible pH lability of cross-linked vault nanocapsules.
M. Yu (2008)
10.1074/jbc.C100226200
Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein*
A. G. Stephen (2001)
10.1083/JCB.103.3.699
Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA
N. Kedersha (1986)
10.1083/JCB.141.6.1301
Interaction of Vault Particles with Estrogen Receptor in the MCF-7 Breast Cancer Cell
C. Abbondanza (1998)
10.1158/1535-7163.MCT-06-0372
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes
Mikael C Herlevsen (2007)
10.1038/emboj.2009.274
The mechanism of vault opening from the high resolution structure of the N-terminal repeats of MVP
Jordi Querol-Audí (2009)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1016/J.JMB.2004.09.021
Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
Y. Mikyas (2004)
10.1021/nn102051r
Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
J. Yang (2010)
10.1021/BI0606243
Vault nanocapsule dissociation into halves triggered at low pH.
Lisa E Goldsmith (2007)
10.1016/0962-8924(96)10014-3
Vaults are the answer, what is the question?
V. Kickhoefer (1996)
10.1021/BI0610552
The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.
Michael J Poderycki (2006)
Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III.
V. Kickhoefer (1993)
10.1016/S1359-6446(03)02623-0
Peptide and protein drug delivery to and into tumors: challenges and solutions.
V. Torchilin (2003)
10.1002/jps.21508
Structural stability of vault particles.
R. Esfandiary (2009)
10.1021/nn800638x
Targeting vault nanoparticles to specific cell surface receptors.
V. Kickhoefer (2009)
10.1074/jbc.M207608200
PTEN Associates with the Vault Particles in HeLa Cells*
Z. Yu (2002)
10.1016/S0969-2126(99)80050-1
Structure of the vault, a ubiquitous celular component.
L. B. Kong (1999)
10.1073/PNAS.0500929102
Engineering of vault nanocapsules with enzymatic and fluorescent properties.
V. Kickhoefer (2005)
10.1007/s00018-008-8364-z
Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity
W. Berger (2008)
10.1371/journal.pone.0018758
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
U. Kar (2011)
10.1021/nl080537r
Encapsulation of semiconducting polymers in vault protein cages.
B. Ng (2008)
10.1126/science.1164975
The Structure of Rat Liver Vault at 3.5 Angstrom Resolution
H. Tanaka (2009)



This paper is referenced by
10.1016/j.biomaterials.2017.04.036
Protein based therapeutic delivery agents: Contemporary developments and challenges.
Liming Yin (2017)
10.1021/BK-2017-1252.CH006
Polypeptides and Engineered Proteins
Xinyu Liu (2017)
10.1039/c5bm00052a
Protein nanoparticles for therapeutic protein delivery.
L. Herrera Estrada (2015)
10.1186/s13058-018-1088-6
Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)
C. Lehuédé (2018)
10.31274/ETD-180810-3765
Role of the PduL enzyme in the function of primitive bacterial organelles found in Salmonella
Y. Liu (2014)
10.1016/j.bpj.2013.12.035
Mechanical stability and reversible fracture of vault particles.
A. Llauró (2014)
10.1002/ADMI.201800118
Self-healing biomaterials : from molecular concepts to clinical applications
M. Diba (2018)
10.1021/acs.biochem.5b01152
Ferritin Assembly Revisited: A Time-Resolved Small-Angle X-ray Scattering Study.
D. Sato (2016)
10.1016/j.actbio.2020.03.020
Advancements in prophylactic and therapeutic nanovaccines
P. Bhardwaj (2020)
10.1038/srep34143
Decrease in pH destabilizes individual vault nanocages by weakening the inter-protein lateral interaction
A. Llauró (2016)
10.1186/s12934-017-0646-4
Cellular factories for coenzyme Q10 production
S. T. H. Lee (2017)
10.1016/j.sbi.2014.05.009
Design and designability of protein-based assemblies.
J. Zhang (2014)
10.1016/j.cbpa.2016.05.013
Encapsulins: microbial nanocompartments with applications in biomedicine, nanobiotechnology and materials science.
Tobias W. Giessen (2016)
Semantic Scholar Logo Some data provided by SemanticScholar